CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022		109,871
Beginning balance at Dec. 31, 2022	$ 324,506	$ 110	$ 2,380,651	$ (2,046,569)	$ (9,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,093			5,093
Other comprehensive income (loss), net of tax	2,031				2,031
Issuance of common stock under stock option, award and purchase plans, net (in shares)		1,461
Issuance of common stock under award and purchase plans, net	(3,268)	$ 1	(3,269)
Stock-based compensation	7,424		7,424
Ending balance (in shares) at Mar. 31, 2023		111,332
Ending balance at Mar. 31, 2023	$ 335,786	$ 111	2,384,806	(2,041,476)	(7,655)
Beginning balance (in shares) at Dec. 31, 2023	112,407	112,407
Beginning balance at Dec. 31, 2023	$ 436,874	$ 112	2,405,043	(1,962,575)	(5,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(8,089)			(8,089)
Other comprehensive income (loss), net of tax	(3,007)				(3,007)
Issuance of common stock under stock option, award and purchase plans, net (in shares)		1,197
Issuance of common stock under award and purchase plans, net	$ (1,871)	$ 1	(1,872)
Repurchase of common stock (in shares)	(1,700)	(1,658)
Repurchase of common stock	$ (21,676)	$ (1)		(21,675)
Stock-based compensation	$ 6,923		6,923
Ending balance (in shares) at Mar. 29, 2024	111,946	111,946
Ending balance at Mar. 29, 2024	$ 409,154	$ 112	$ 2,410,094	$ (1,992,339)	$ (8,713)